Shares of Envista Holdings Corporation (NYSE:NVST - Get Free Report) have earned a consensus recommendation of "Hold" from the fifteen brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, nine have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $20.9231.
NVST has been the topic of several research reports. Bank of America reduced their price target on Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Stifel Nicolaus boosted their price target on Envista from $24.00 to $25.00 and gave the stock a "buy" rating in a report on Friday, August 1st. Wells Fargo & Company boosted their price target on Envista from $17.00 to $19.00 and gave the stock an "equal weight" rating in a report on Friday, August 1st. Robert W. Baird upgraded Envista from a "neutral" rating to an "outperform" rating and upped their target price for the company from $21.00 to $23.00 in a report on Tuesday, May 27th. Finally, UBS Group upped their target price on Envista from $18.00 to $22.00 and gave the company a "neutral" rating in a report on Tuesday, July 29th.
Check Out Our Latest Report on NVST
Hedge Funds Weigh In On Envista
Institutional investors and hedge funds have recently modified their holdings of the business. UMB Bank n.a. raised its position in shares of Envista by 214.4% during the first quarter. UMB Bank n.a. now owns 2,094 shares of the company's stock worth $36,000 after purchasing an additional 1,428 shares during the period. Parallel Advisors LLC raised its position in shares of Envista by 100.1% during the second quarter. Parallel Advisors LLC now owns 2,792 shares of the company's stock worth $55,000 after purchasing an additional 1,397 shares during the period. Palouse Capital Management Inc. raised its position in shares of Envista by 14.4% during the first quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company's stock worth $163,000 after purchasing an additional 1,186 shares during the period. FourThought Financial Partners LLC acquired a new position in shares of Envista during the first quarter worth approximately $180,000. Finally, Vestcor Inc acquired a new position in shares of Envista during the first quarter worth approximately $211,000.
Envista Stock Down 0.3%
Shares of NYSE NVST opened at $20.19 on Tuesday. The company has a current ratio of 2.44, a quick ratio of 2.08 and a debt-to-equity ratio of 0.46. The company has a market cap of $3.35 billion, a price-to-earnings ratio of 63.08, a PEG ratio of 1.08 and a beta of 1.00. Envista has a 12 month low of $14.22 and a 12 month high of $23.00. The stock has a 50-day moving average price of $19.67 and a two-hundred day moving average price of $18.58.
Envista (NYSE:NVST - Get Free Report) last issued its earnings results on Thursday, July 31st. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.24 by $0.02. The firm had revenue of $682.10 million during the quarter, compared to the consensus estimate of $638.21 million. Envista had a return on equity of 4.84% and a net margin of 2.11%. The business's quarterly revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.11 earnings per share. As a group, analysts forecast that Envista will post 1 earnings per share for the current fiscal year.
Envista Company Profile
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.